Oral Oncology
Volume 46, Issue 4 , Pages 276-282, April 2010

Surgical outcomes and prognostic factors of oral cancer associated with betel quid chewing and tobacco smoking in Taiwan

  • Shyun-Yeu Liu

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Yongkang, Taiwan
    • Department of Medical Research, Chi-Mei Medical Center, Taiwan
  • ,
  • Chin-Li Lu

      Affiliations

    • Department of Medical Research, Chi-Mei Medical Center, Taiwan
  • ,
  • Chang-Ta Chiou

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Chang-Gung Memorial Hospital, Kaohsiung, Taiwan
  • ,
  • Ching-Yu Yen

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Yongkang, Taiwan
  • ,
  • Gwo-An Liaw

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Liouying, Taiwan
  • ,
  • Yi-Chun Chen

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
  • ,
  • Yu-Chi Liu

      Affiliations

    • Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan
  • ,
  • Wei-Fan Chiang

      Affiliations

    • Department of Medical Research, Chi-Mei Medical Center, Taiwan
    • Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Liouying, Taiwan
    • School of Dentistry, National Yang-Ming University, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Department of Oral and Maxillofacial Surgery, Chi-Mei Medical Center, Liouying. 201, Taikang Village, Liouying, Tainan 735, Taiwan. Tel.: +886 6 6226999x73158.

Received 8 December 2009; received in revised form 13 January 2010; accepted 14 January 2010. published online 08 February 2010.

Summary 

Oral squamous cell carcinoma (OSCC) is one of the most common cancers in geographic regions where betel quid (BQ) chewing is prevalent; OSCC is an extremely malignant neoplasm whose prognostic factors are multiple and complex. The purpose of this study was to assess clinicopathological prognostic factors and treatment outcomes in 698 consecutive OSCC patients who had undergone surgery as the primary treatment in an area with a high prevalence of both betel quid chewing and tobacco smoking. The prognostic factors were predicted using Cox’s proportional-hazards regression model, and the survival rate was calculated using Kaplan–Meier analysis. The median followup for all patients was 44months. The 5-year cumulative overall, disease-specific, and locoregional control survival rates were 61%, 62%, and 46%, respectively. Multivariate analysis showed that the lower level of nodal metastasis, advanced stage, tumor thickness >7mm, and treatment failures were independent risk factors of overall survival. Furthermore, history of alcohol drinking, lower level of nodal metastasis, advanced stage, poor cell differentiation, and treatment failures were independent predictors of poor disease-specific survival. However, we did not find any significant factor that affected locoregional recurrence. Due to the high frequencies of locoregional recurrence and second primary cancer, our findings emphasize that aggressive surgical excision, adjuvant treatments according to clinicopathological prognostic factors and close surveillance are important to the survival of OSCC patients in an area with a high prevalence of betel quid chewing and tobacco smoking.

Keywords: Oral cancer, Betel quid, Occult metastasis, Second primary cancer, Level of nodal metastasis, Tumor thickness, Alcohol drinking, Treatment failure, Locoregional recurrence, Close surveillance

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(10)00020-5

doi:10.1016/j.oraloncology.2010.01.008

Oral Oncology
Volume 46, Issue 4 , Pages 276-282, April 2010